Cleared Special

K160681 - CenterCross Ultra Catheter

K160681 is an FDA 510(k) clearance for CenterCross Ultra Catheter, manufactured by Roxwood Medical, Inc.. The device is a Class 2 Cardiovascular device with product code DQY cleared through the Special 510(k) pathway after a 99-day FDA review.

K160681 · Roxwood Medical, Inc. · Cardiovascular device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Jun 2016
Decision
99d
Days
Class 2
Risk

K160681 is an FDA 510(k) clearance for the CenterCross Ultra Catheter. Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by Roxwood Medical, Inc. (Redwood City, US). The FDA issued a Cleared decision on June 17, 2016 after a review of 99 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

FDA 510(k) Submission Details - K160681

510(k) Number K160681 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 10, 2016
Decision Date June 17, 2016
Days to Decision 99 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
26d faster than avg
Panel avg: 125d · This submission: 99d
Pathway characteristics
Modification to existing cleared device.

DQY Device Classification - Class 2, Special Controls

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 855
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K160681.
SIDEKICK and USHER Support Catheters
K161986 · Bard Peripheral Vascular, Inc. · Aug 2016
Wingman 18 Crossing Catheter
K160848 · Reflow Medical, Inc. · Jul 2016
ARTLINE
K160448 · Health Line International Corporation · Jul 2016
ASAHI Corsair Armet
K161362 · Asahi Intecc Co., Ltd. · Jun 2016
Guiding Catheter
K153703 · Texasmedical Technologies, Inc. · May 2016
NovaCross Microcatheter
K160389 · Nitiloop , Ltd. · Mar 2016